Lilly CEO Eyes Bigger Deals in Hunt for Pharma’s ‘White Spaces’
Deals·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Eli Lilly & Co. is expected to pursue larger acquisitions, similar to its $7.8 billion deal for Centessa Pharmaceuticals Plc. CEO Dave Ricks indicated that the company is casting a wide net for assets in the unexplored areas of science.
Investors should anticipate these strategic moves as Lilly aims to enhance its portfolio and capitalize on emerging opportunities within the pharmaceutical sector.
Eli LillyCentessa PharmaceuticalsDave Ricks
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Investors should expect Eli Lilly & Co. to strike slightly larger deals, along the lines of its $7.8 billion acquisition of Centessa Pharmaceuticals Plc, as it casts a wide net for assets in the “white spaces” of science, Chief Executive Officer Dave Ricks said.”
Bloomberg — Lilly CEO Eyes Bigger Deals in Hunt for Pharma’s ‘White Spaces’